1 / 14

Holly’s Work Progress in 08-177

Holly’s Work Progress in 08-177. Dec 2008 - July 2009. Outline. ELISA assays of 6 inbred strains of mice 08-177 B6C3H F2 work progress. ~35 inbred strains in plan, 17% completion. ELISA assays of 6 inbred strains of mice.

gwylan
Download Presentation

Holly’s Work Progress in 08-177

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Holly’s Work Progress in 08-177 Dec 2008 - July 2009

  2. Outline • ELISA assays of 6 inbred strains of mice • 08-177 B6C3H F2 work progress

  3. ~35 inbred strains in plan, 17% completion ELISA assays of 6 inbred strains of mice

  4. At baseline sRANKL level varies among different strains: C3H and B6 are much higher than NOD/Ltj, A/J, 129/SvimJ, and CAST/Ei is the lowest Following 3wks 100ppm F treatment, only A/J see significant dose response decrease by 64% (p<0.01) Plasma sRANKL ELISA Assays of Inbred Strains of mice

  5. At baseline, A/J and 129/SvimJ PTH level is higher than that of C3H and B6 Following 3wks 100ppm F treatment, A/J sees dose response decrease by 31% (p<0.1), but no significant changes in B6, C3H or 129/SvimJ. Plasma Intact PTH ELISA assays of inbred strains of mice

  6. Serum PTH of F treated (50ppm, 60days) A/J is higher than that of untreated Serum Intact PTH ELISA Assays

  7. Old F2 Genotyping Samples Preparation • 187 genomic DNA samples prepared from previous F2 mice livers/spleens • 140 of 187 samples sent to Jackson Lab in Jun2009

  8. 08-177 B6C3HF2 work progress

  9. B6C3H F2 Treatment Plan

  10. 08-177 B6C3HF2 – Genotyping • 212 genomic DNA samples prepared from 08-177 B6C3HF2 mice livers/Spleens • 156 of 212 samples sent to HPCPG in July 09; the rest of 56 ready to be sent in Aug 09

  11. 08-177 B6C3HF2 – sRANKL ELISA Assays See Hongyou’s presentation

  12. Results & Discussion • At baseline, sRANKL level or intact PTH level varies among different strains; • Following 3 wks of 100ppm F treatment, different strains response differently. Among 6 inbred strains only A/J see significant dose response decrease of sRANKL by 64% (p<0.01) and decrease of intact PTH by 31% (p<0.1), which did not show the similar trend of previous results (Dong Y 2007) – different anesthesia? Serum vs Plasma? F in diet? different length of treatment?...

  13. Future work • Continue work on more inbred strains and B6C3HF2s • Mini study to check the impact of anaethesia (Ketamine/Xylazine or Avertin) on serum or plasma PTH level using ALPCO PTH ELISA kit and verify the effect of fluoride treatment on PTH level. • 40 male C3H mice, 8 groups of 5.

  14. Questions …? Thanks!

More Related